Completed PHASE4 INTERVENTIONAL 2-arm NCT01279070

Efficacy of Repyflec Cognitive Remediation Group Training in Schizophrenia

Efficacy of Repyflec Cognitive Remediation Group Training in Cognition, Functional Outcomes and Psychiatric Symptoms of Outpatients With Schizophrenia.

Sponsor: Fundació Sant Joan de Déu

Conditions Indication for Modification of Patient Cognitive Status

Interventions Repyflec cognitive remediation training

Updated 6 times since 2017 Last updated: Aug 14, 2013 Started: Sep 30, 2006 Primary completion: Jan 31, 2009 Completion: Mar 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01279070, this PHASE4 trial focuses on Indication for Modification of Patient Cognitive Status and remains completed. Sponsored by Fundació Sant Joan de Déu, it has been updated 6 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Dec 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Dec 2021 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundació Sant Joan de Déu

Data source: Fundació Sant Joan de Déu

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sant Boi de Llobregat, Spain